drugset
drugset / Trial / NCT00454753

Expanded Access for Dasatinib

NCT00454753 ↗

Expanded access No longer available Bristol-Myers Squibb

Summary

This is an expanded access designed to provide access to dasatinib for eligible participants.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background dasatinib anhydrous Small molecule — —

Indications

No indication recorded.